Inventor

STAMFORD ANDREW W

US63 patents

⚠️ This page may combine multiple inventors who share the name “STAMFORD ANDREW W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STAMFORD ANDREW W

MERCK SHARP & DOHME

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use

Iminothiadiazine dioxide compounds as brace inhibitors, compositions, and their use

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use

Substituted aminoquinazoline compounds as A2A antagonist

Factor XIa inhibitors

C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their use

Diazine-fused amidines as BACE inhibitors, compositions, and their use

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use

C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use

Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use

Heterocyclic aspartyl protease inhibitors

Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use

Preparation and use of compounds as protease inhibitors

Substituted amide beta secretase inhibitors

Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment

SCHERING CORP

Xanthine phosphodiesterase V inhibitors

Neuropeptide Y5 receptor antagonists

Substituted urea neuropeptide Y Y5 Receptor antagonists

Substituted imidazole neuropeptide Y Y5 receptor antagonists

Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors

Substituted piperazines as CB1 antagonists

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Substituted imidazole neuropeptide Y Y5 receptor antagonists

Polycyclic guanine derivative phosphodiesterase V inhibitors

Macrocyclic beta-secretase inhibitors

Substituted amide beta secretase inhibitors

Aspartyl protease inhibitors

Xanthine phosphodiesterase V inhibitors

Neuropeptide Y Y5 receptor antagonists

ZHU ZHAONING

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

SCOTT JACK D

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use

Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use

SCHERING PLOUGH CORP

Neuropeptide Y Y5 receptor antagonists

Macrocyclic β-secretase inhibitors

STAMFORD ANDREW W

Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions, and their use

Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use

CUMMING JARED N

C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use

ISERLOH ULRICH

Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions and their use

BAO JIANMING

6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor

WU WEN-LIAN

5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use

HARRIS JOEL M

Substituted [1,2,4]triazolo[4,3-alpha]quinoxalines as adenosine A2a receptor antagonists

GILBERT ERIC J

Substituted piperazines as CB1 antagonists

BOYLE CRAIG D

Pyrimidinone derivatives and methods of use thereof